Groundbreaking developments in HIV treatments have slowly begun to transition the disease into a chronic condition. Thankfully, patients are able to live long and full
Colorectal cancer screening (CRC) programs around the world have been disrupted by the COVID-19 pandemic. To explore the impact of disruptions to cancer screening of
Red blood cell transfusions are common in patients who undergo surgery for gastrointestinal (GI) cancer. These patients are at high risk for requiring transfusions because
DDW Council Chair, Loren Laine, MD, looks back on this year’s annual meeting and highlights some of the most interesting research presented at the meeting.
With the increased availability of safe and effective treatments for patients with hepatitis C (HCV), Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS, identified five HCV patient populations clinicians should understand how to treat.
Prateek Sharama, MD, provided a checklist for clinicians and organizations as endoscopic services resume post COVID-19 to ensure safe and efficient operation.
Kenneth Wang, MD, reviewed recent innovations in cryotherapy and tissue resection that are improving outcomes for patients with Barrett’s esophagus, especially those who have failed standard therapy.
Joseph C. Anderson, MD, FACG, MHCDS, provided a review of the best time to start and stop screening for colorectal cancer (CRC) to detect the cancer early and to prevent unnecessary screening.
Jacob E. Kurlander, MD, MS, of the Veterans Affairs (VA) Center for Clinical Management Research and Michigan Medicine shared data on the largest PPI deprescribing intervention in Veterans, showing that these programs help reduce PPI prescribing, without increasing adverse events.
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections.
